GLP-1 weight loss drugs may be misused by patients with eating disorders: Study
New research highlights concerns over the potential misuse of GLP-1 receptor agonist medications among individuals diagnosed with eating disorders.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
A study published in JAMA indicates that patients with eating disorders are utilizing GLP-1 weight-loss medications in ways that may sustain disordered eating patterns. Reports suggest these prescriptions are being employed as a means to maintain control over body weight and food intake.
Coverage from outlets including NewsNation, MedPage Today, ABC News, and Medical Dialogues emphasizes findings that link these drugs to broader patterns of misuse within specific patient populations. Psychology Today notes that for some users, the pursuit of control through these medications acts as a symptom of underlying conditions rather than a successful health outcome.
Future developments will depend on further clinical analysis of how medical practitioners screen patients for pre-existing eating disorders before prescribing GLP-1 agonists. The extent to which these findings influence prescribing guidelines remains to be seen.
Synthesized by PULSE from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 135d ago.
Quick answers
What does the study suggest about GLP-1 usage?
The study suggests that some patients with eating disorders are using GLP-1 receptor agonists as a tool to sustain disordered eating behaviors.
Where were these findings published?
The findings were reported in a study published in JAMA, as cited by multiple news organizations.
What is the primary concern for clinicians?
Coverage indicates that the primary concern is the potential for these medications to be misused by individuals suffering from eating disorders to maintain a sense of control.
Coverage (9)
- For some patients, feeling in control is a symptom, not the outcome. Psychology Today · 138d ago
- GLP-1 Receptor Agonist Use and Misuse Common Among People With Eating Disorders: JAMA Medical Dialogues · 138d ago
- GLP-1s may be misused by patients with eating disorders: Study NewsNation · 138d ago
- For some patients, feeling in control is a symptom, not the outcome. Psychology Today · 138d ago
- Are People With Eating Disorders Misusing GLP-1 Drugs? MedPage Today · 138d ago
- Health Beat: Study reveals eating disorder patients misuse weight-loss injections at alarming rate WFMZ.com · 138d ago
- GLP-1 RAs being used to sustain eating disorders Medical Republic · 138d ago
- People With Eating Disorders Are Misusing Ozempic Gizmodo · 138d ago
- GLP-1 weight loss drugs may be misused by patients with eating disorders: Study ABC News - Breaking News, Latest News and Videos · 138d ago
Topics
Related trends
FDA orders new warning labels on Ozempic, Wegovy over rare risk of permanent vision loss
Federal regulators mandate new vision loss warning labels across the widely used GLP-1 receptor agonist drug class.
A defining moment for RFK Jr.
Ohio measles surge intensifies as RFK Jr. faces defining moment on vaccine policy amid rising cases.
FDA tells GLP-1 makers to warn of potential vision loss side effect
The FDA is requiring all GLP-1 drug makers to add warnings about a possible increased risk of NAION, a rare eye condition that can cause sudden and permanent vision loss.
Her Death From Dengue May Signal That the Disease Is Here to Stay
Florida faces a historic dengue fever outbreak as record spreads prompt urgent questions about weather impacts and environmental factors.
Hers Health, Inc. Reports Third Quarter 2026 Financial Results
Hims & Hers Health reported Q3 2026 revenue of $401.6 million, up 69% year over year, but narrowed its full-year revenue guidance and cut its adjusted EBITDA forecast, sending shares down sharply.
Survival after sudden cardiac arrest didn’t improve despite training bystanders, emergency responders
A five-year North Carolina trial found that expanding CPR training, 911 dispatcher coaching, and early defibrillation across 31 counties did not improve survival after out-of-hospital cardiac arrest compared with 29 counties using usual care.